Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The cancer stem cell paradigm: a new understanding of tumor development and treatment.

Ebben JD, Treisman DM, Zorniak M, Kutty RG, Clark PA, Kuo JS.

Expert Opin Ther Targets. 2010 Jun;14(6):621-32. doi: 10.1517/14712598.2010.485186. Review.

2.

Cancer stem cells: a guide for skeptics.

Tomasson MH.

J Cell Biochem. 2009 Apr 1;106(5):745-9. doi: 10.1002/jcb.22050. Review.

PMID:
19184979
3.

[Tumor stem cell research - basis and challenge for diagnosis and therapy].

Karlic H, Herrmann H, Schulenburg A, Grunt TW, Laffer S, Mirkina I, Hubmann R, Shehata M, Marian B, Selzer E, Pfeilstöcker M, Pittermann E, Jäger U, Pehamberger H, Zielinski C, Valent P.

Wien Klin Wochenschr. 2010 Jul;122(13-14):423-36. doi: 10.1007/s00508-010-1408-z. Epub 2010 Jul 22. Review. German.

PMID:
20645015
4.

Cancer stem cells and chemoresistance: The smartest survives the raid.

Zhao J.

Pharmacol Ther. 2016 Apr;160:145-58. doi: 10.1016/j.pharmthera.2016.02.008. Epub 2016 Feb 17. Review.

PMID:
26899500
5.

Cancer stem cell targeting: the next generation of cancer therapy and molecular imaging.

Shigdar S, Lin J, Li Y, Yang CJ, Wei M, Zhus Y, Liu H, Duan W.

Ther Deliv. 2012 Feb;3(2):227-44. Review.

PMID:
22834199
6.

Targeting Notch to target cancer stem cells.

Pannuti A, Foreman K, Rizzo P, Osipo C, Golde T, Osborne B, Miele L.

Clin Cancer Res. 2010 Jun 15;16(12):3141-52. doi: 10.1158/1078-0432.CCR-09-2823. Epub 2010 Jun 8. Review.

7.

Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.

Ranji P, Salmani Kesejini T, Saeedikhoo S, Alizadeh AM.

Tumour Biol. 2016 Oct;37(10):13059-13075. Epub 2016 Aug 26. Review.

PMID:
27561758
8.

Cancer stem cells: a review of potential clinical applications.

Podberezin M, Wen J, Chang CC.

Arch Pathol Lab Med. 2013 Aug;137(8):1111-6. doi: 10.5858/arpa.2012-0494-RA. Epub 2012 Nov 15. Review.

PMID:
23153183
9.

Tumor dormancy and cancer stem cells: two sides of the same coin?

Kleffel S, Schatton T.

Adv Exp Med Biol. 2013;734:145-79. doi: 10.1007/978-1-4614-1445-2_8.

PMID:
23143979
10.

Lung cancer stem cells: tumor biology and clinical implications.

Nurwidya F, Murakami A, Takahashi F, Takahashi K.

Asia Pac J Clin Oncol. 2012 Sep;8(3):217-22. doi: 10.1111/j.1743-7563.2012.01550.x. Epub 2012 May 21. Review.

PMID:
22897822
11.
12.

Tumor initiating cells.

Bansal N, Banerjee D.

Curr Pharm Biotechnol. 2009 Feb;10(2):192-6. Review.

PMID:
19199951
13.

Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.

Malhi S, Gu X.

Expert Opin Drug Deliv. 2015 Jul;12(7):1177-201. doi: 10.1517/17425247.2015.998648. Epub 2015 Jan 20. Review.

PMID:
25601619
14.

Cancer stem cells and self-renewal.

O'Brien CA, Kreso A, Jamieson CH.

Clin Cancer Res. 2010 Jun 15;16(12):3113-20. doi: 10.1158/1078-0432.CCR-09-2824. Epub 2010 Jun 8. Review.

15.

Dynamic regulation of cancer stem cells and clinical challenges.

Ni C, Huang J.

Clin Transl Oncol. 2013 Apr;15(4):253-8. doi: 10.1007/s12094-012-0927-7. Epub 2012 Aug 28. Review.

PMID:
22926945
16.

Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine.

Winquist RJ, Boucher DM, Wood M, Furey BF.

Biochem Pharmacol. 2009 Aug 15;78(4):326-34. doi: 10.1016/j.bcp.2009.03.020. Epub 2009 Apr 1.

PMID:
19539800
17.

Natural Products That Target Cancer Stem Cells.

Moselhy J, Srinivasan S, Ankem MK, Damodaran C.

Anticancer Res. 2015 Nov;35(11):5773-88. Review.

PMID:
26503998
18.

Cancer stem cells niche: a target for novel cancer therapeutics.

Yi SY, Hao YB, Nan KJ, Fan TL.

Cancer Treat Rev. 2013 May;39(3):290-6. doi: 10.1016/j.ctrv.2012.10.004. Epub 2012 Dec 5. Review.

PMID:
23219150
19.

Metastatic cancer stem cells: new molecular targets for cancer therapy.

Leirós GJ, Balañá ME.

Curr Pharm Biotechnol. 2011 Nov;12(11):1909-22. Review.

PMID:
21470128
20.

Supplemental Content

Support Center